125 related articles for article (PubMed ID: 1871541)
1. Failure of sucralfate in the treatment of refractory esophagitis versus high-dose famotidine. An endoscopic study.
Pace F; Lazzaroni M; Bianchi Porro G
Scand J Gastroenterol; 1991 May; 26(5):491-4. PubMed ID: 1871541
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effect of sucralfate and ranitidine in reflux esophagitis.
Simon B; Mueller P
Am J Med; 1987 Sep; 83(3B):43-7. PubMed ID: 3310628
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of sucralfate and ranitidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis.
Vermeijden JR; Tytgat GN; Schotborgh RH; Dekker W; vd Boomgaard DM; van Olffen GH; Schrijver M; Vosmaer GD; Dekkers CP
Scand J Gastroenterol; 1992; 27(2):81-4. PubMed ID: 1561531
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis.
Schotborgh RH; Hameeteman W; Dekker W; vd Boomgaard DM; Van Olffen GH; Schrijver M; Vosmaer GD; Tytgat GN
Am J Med; 1989 Jun; 86(6A):77-80. PubMed ID: 2660561
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.
Simon TJ; Berlin RG; Tipping R; Gilde L
Scand J Gastroenterol; 1993 May; 28(5):375-80. PubMed ID: 8511496
[TBL] [Abstract][Full Text] [Related]
6. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study.
Carling L; Cronstedt J; Engqvist A; Kagevi I; Nyström B; Svedberg LE; Thorhallsson E; Unge P; Wingren PE
Scand J Gastroenterol; 1988 Nov; 23(9):1117-24. PubMed ID: 3073524
[TBL] [Abstract][Full Text] [Related]
7. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis.
Williams RM; Orlando RC; Bozymski EM; Readling RD; Castell DO; Roufail WM; Rick GG; Rubin SE; Sinar DR
Am J Med; 1987 Sep; 83(3B):61-6. PubMed ID: 3310630
[TBL] [Abstract][Full Text] [Related]
8. Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.
Bremner CG; Marks IN; Segal I; Simjee A
Am J Med; 1991 Aug; 91(2A):119S-122S. PubMed ID: 1882897
[TBL] [Abstract][Full Text] [Related]
9. Sucralfate versus cimetidine in reflux oesophagitis. A double-blind clinical study.
Elsborg L; Jørgensen F
Scand J Gastroenterol; 1991 Feb; 26(2):146-50. PubMed ID: 2011701
[TBL] [Abstract][Full Text] [Related]
10. Sucralfate in the treatment of reflux esophagitis in adults: an update.
Simon B; Dammann HG; Müller P
Scand J Gastroenterol Suppl; 1989; 156():37-41. PubMed ID: 2662389
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis.
Wesdorp IC; Dekker W; Festen HP
Dig Dis Sci; 1993 Dec; 38(12):2287-93. PubMed ID: 8261835
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study.
Ros E; Pujol A; Bordas JM; Grande L
Scand J Gastroenterol Suppl; 1989; 156():49-55. PubMed ID: 2740842
[TBL] [Abstract][Full Text] [Related]
13. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
[TBL] [Abstract][Full Text] [Related]
14. Healing of erosive esophagitis with sucralfate and cimetidine: influence of pretreatment lower esophageal sphincter pressure and serum pepsinogen I levels.
Ros E; Toledo-Pimentel V; Bordas JM; Grande L; Lacima G; Segu L
Am J Med; 1991 Aug; 91(2A):107S-113S. PubMed ID: 1882895
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
Vasil'ev IuV; Li IA
Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of sucralfate in reflux esophagitis. Comparison with cimetidine.
Tytgat GN
Am J Med; 1987 Sep; 83(3B):38-42. PubMed ID: 3661610
[TBL] [Abstract][Full Text] [Related]
17. High-dose famotidine in the maintenance treatment of refractory esophagitis: results of a "medium-term" open study.
Bianchi-Porro G; Pace F; Sangaletti O; Peracchia A; Bonavina L; Vigneri S; Termini R
Am J Gastroenterol; 1991 Nov; 86(11):1585-7. PubMed ID: 1951234
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis.
Ohara S; Haruma K; Kinoshita Y; Kusano M
J Gastroenterol; 2010 Dec; 45(12):1219-27. PubMed ID: 20632193
[TBL] [Abstract][Full Text] [Related]
19. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children.
Argüelles-Martin F; Gonzalez-Fernandez F; Gentles MG
Am J Med; 1989 Jun; 86(6A):73-6. PubMed ID: 2735338
[TBL] [Abstract][Full Text] [Related]
20. Sucralfate maintenance therapy in reflux esophagitis. Sucralfate Investigational Working Team.
Tytgat GN; Koelz HR; Vosmaer GD
Am J Gastroenterol; 1995 Aug; 90(8):1233-7. PubMed ID: 7639221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
